Roivant Sciences (ROIV) News Today $10.19 +0.33 (+3.35%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Geode Capital Management LLC Acquires 26,727 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Geode Capital Management LLC increased its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 0.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 7,771,831 shares of the company's stock after buying an additional 26,727 shares dApril 13 at 4:39 AM | marketbeat.comIs Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 12 at 9:38 PM | finance.yahoo.comIs Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?April 11 at 4:08 PM | insidermonkey.comFmr LLC Has $583.24 Million Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Fmr LLC boosted its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 0.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,301,583 shares of the company's stock after acquirinApril 11 at 5:45 AM | marketbeat.comRoivant Sciences Ltd. (ROIV): Among the Best Low Priced Growth Stocks to Invest InApril 10, 2025 | insidermonkey.comRoivant Sciences (NASDAQ:ROIV) Hits New 1-Year Low - What's Next?Roivant Sciences (NASDAQ:ROIV) Hits New 12-Month Low - Here's What HappenedApril 9, 2025 | marketbeat.comADAR1 Capital Management LLC Increases Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)ADAR1 Capital Management LLC raised its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 16.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,508,694 shares of the company's stock after acquiring an additional 483,244 shares duriApril 9, 2025 | marketbeat.comNorges Bank Invests $52.44 Million in Roivant Sciences Ltd. (NASDAQ:ROIV)Norges Bank acquired a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 4,433,014 shares of the company's stock, valued at approximately $52,443,000. NorApril 6, 2025 | marketbeat.comRangeley Capital LLC Takes $2.83 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Rangeley Capital LLC bought a new position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 239,000 shares of the company's stock, valued at approximatelyApril 5, 2025 | marketbeat.comBryce Point Capital LLC Purchases Shares of 96,550 Roivant Sciences Ltd. (NASDAQ:ROIV)Bryce Point Capital LLC acquired a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 96,550 shares of the company's stock, valued at approximatApril 5, 2025 | marketbeat.comRaymond James Financial Inc. Purchases New Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Raymond James Financial Inc. bought a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 84,091 shares of the company's stock, valued at approximately $995,April 5, 2025 | marketbeat.comPictet Asset Management Holding SA Cuts Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Pictet Asset Management Holding SA reduced its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 15.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 927,470 shares of the company's stock after sApril 4, 2025 | marketbeat.comTe Ahumairangi Investment Management Ltd Has $1.87 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Te Ahumairangi Investment Management Ltd decreased its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 21.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,011 shares of the compApril 3, 2025 | marketbeat.comKnott David M Jr Has $47,000 Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Knott David M Jr cut its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 93.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,005 shares of the company's stock after selling 5April 2, 2025 | marketbeat.comVanguard Group Inc. Increases Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Vanguard Group Inc. increased its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 5.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,087,287 shares of the company's stock after acquiring an additional 2April 2, 2025 | marketbeat.com77,600 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Purchased by KLP Kapitalforvaltning ASKLP Kapitalforvaltning AS bought a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 77,600 shares of the company's stock, valued at approximately $918,000. A numApril 2, 2025 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Sets New 1-Year Low - Should You Sell?Roivant Sciences (NASDAQ:ROIV) Reaches New 12-Month Low - Here's WhyApril 1, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Holdings Decreased by Corebridge Financial Inc.Corebridge Financial Inc. trimmed its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 5.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 485,952 shares of the company's stock after selling 29,93March 31, 2025 | marketbeat.comPertento Partners LLP Acquires 646,865 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Pertento Partners LLP raised its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,484,918 shares of the company's stock after purchasing an additional 646,865 shares durinMarch 30, 2025 | marketbeat.comIs the Biotech Sector Oversaturated?March 30, 2025 | uk.finance.yahoo.comLoomis Sayles & Co. L P Trims Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Loomis Sayles & Co. L P trimmed its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 6.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,671,011 shares of the company's stock after selling 241,194 shares during theMarch 29, 2025 | marketbeat.comNatixis Advisors LLC Has $611,000 Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Natixis Advisors LLC lessened its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 66.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 51,620 shares of the company's stock after selling 102,097 shares duMarch 27, 2025 | marketbeat.comEric Venker, président de Roivant Sciences, vend des actions d’une valeur de 8,19 millionsMarch 26, 2025 | fr.investing.comEFG Asset Management North America Corp. Has $3.82 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)EFG Asset Management North America Corp. reduced its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 8.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 322,734 shares of the company'sMarch 26, 2025 | marketbeat.comEntryPoint Capital LLC Acquires 40,964 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)EntryPoint Capital LLC raised its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 328.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 53,443 shares of the company's stock after purchasingMarch 26, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $3,489,673.32 in StockRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) COO Eric Venker sold 315,522 shares of the firm's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $11.06, for a total value of $3,489,673.32. Following the sale, the chief operating officer now directly owns 959,457 shares of the company's stock, valued at $10,611,594.42. The trade was a 24.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.March 25, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 434,478 SharesRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) COO Eric Venker sold 434,478 shares of the company's stock in a transaction on Monday, March 24th. The stock was sold at an average price of $10.82, for a total value of $4,701,051.96. Following the sale, the chief operating officer now owns 1,127,290 shares of the company's stock, valued at $12,197,277.80. This trade represents a 27.82 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.March 25, 2025 | marketbeat.comIs Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn?March 25, 2025 | insidermonkey.comInsider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 315,522 Shares of StockMarch 25, 2025 | insidertrades.comRoivant Sciences finalizes consulting agreement with former officerMarch 22, 2025 | investing.comRoivant Sciences Ltd. (NASDAQ:ROIV) Holdings Lessened by Corbin Capital Partners L.P.Corbin Capital Partners L.P. reduced its holdings in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 69.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,641 shares of the company's stock afMarch 22, 2025 | marketbeat.comRoivant Sciences finalise un accord de conseil avec une ancienne dirigeanteMarch 21, 2025 | fr.investing.comRoivant Sciences (NASDAQ:ROIV) Trading Up 5% - Here's WhyRoivant Sciences (NASDAQ:ROIV) Trading 5% Higher - Time to Buy?March 20, 2025 | marketbeat.comPrivium Fund Management B.V. Cuts Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Privium Fund Management B.V. reduced its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 55.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 215,506 shares of the company's stock after sellingMarch 20, 2025 | marketbeat.comRoivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rose.March 19, 2025 | msn.comRoivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rallied.March 19, 2025 | msn.comRoivant, Immunovant Succeed In Phase 3. But There's A Twist — And Shares Tumbled.March 19, 2025 | investors.comRoivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) StudiesMarch 19, 2025 | globenewswire.comTejara Capital Ltd Cuts Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Tejara Capital Ltd decreased its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 42.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 813,550 shares of the company's stock after selling 607,440 shares during the period. Roivant SciencesMarch 19, 2025 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Buy" from AnalystsShares of Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have given aMarch 19, 2025 | marketbeat.comRoivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) ProgramsMarch 18, 2025 | globenewswire.comSkandinaviska Enskilda Banken AB publ Reduces Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Skandinaviska Enskilda Banken AB publ lessened its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 42.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 115,476 shares of the company's sMarch 18, 2025 | marketbeat.comAmundi Raises Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Amundi raised its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 15.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 337,515 shares of the company's stock after purchasing an addMarch 17, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Charles Schwab Investment Management Inc. raised its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 1.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,812,502 sharesMarch 17, 2025 | marketbeat.comMonimus Capital Management LP Purchases Shares of 137,058 Roivant Sciences Ltd. (NASDAQ:ROIV)Monimus Capital Management LP purchased a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 137,058 shares of the company's stock, valued at approximately $1,621,000. Roivant SciMarch 16, 2025 | marketbeat.comMonaco Asset Management SAM Acquires 35,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Monaco Asset Management SAM grew its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 35.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 135,000 shares of the company's stock after purchaMarch 15, 2025 | marketbeat.comThompson Siegel & Walmsley LLC Increases Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Thompson Siegel & Walmsley LLC increased its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 10.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 565,337 shares of the company's stockMarch 15, 2025 | marketbeat.comRoivant at Leerink’s Conference: Strategic Insights and DevelopmentsMarch 12, 2025 | investing.comDoes Roivant (ROIV) Offer an Attractive Risk Reward Opportunity?March 7, 2025 | msn.comBank of New York Mellon Corp Boosts Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Bank of New York Mellon Corp boosted its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 17.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,439,540 shares of the company's stock after purchasing an additional 510,398 shareMarch 7, 2025 | marketbeat.com Remove Ads Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address ROIV Media Mentions By Week ROIV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIV News Sentiment▼1.251.00▲Average Medical News Sentiment ROIV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIV Articles This Week▼85▲ROIV Articles Average Week Remove Ads Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ONC News Today BNTX News Today TEVA News Today ITCI News Today SMMT News Today GMAB News Today RDY News Today MRNA News Today VTRS News Today QGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIV) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ROIV Stock Free ROIV Stock Alerts